A detailed history of Jump Financial, LLC transactions in Brainstorm Cell Therapeutics Inc. stock. As of the latest transaction made, Jump Financial, LLC holds 10,995 shares of BCLI stock, worth $18,801. This represents 0.0% of its overall portfolio holdings.

Number of Shares
10,995
Holding current value
$18,801
% of portfolio
0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$0.22 - $0.42 $2,418 - $4,617
10,995 New
10,995 $2,000
Q4 2020

Feb 12, 2021

SELL
$3.99 - $17.73 $43,890 - $195,030
-11,000 Closed
0 $0
Q3 2020

Nov 13, 2020

BUY
$11.19 - $16.92 $123,090 - $186,120
11,000 New
11,000 $186,000

Others Institutions Holding BCLI

About BRAINSTORM CELL THERAPEUTICS INC.


  • Ticker BCLI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 36,486,200
  • Market Cap $62.4M
  • Description
  • Brainstorm Cell Therapeutics Inc., a biotechnology company, engages in the development and commercialization of autologous cellular therapies for the treatment of neurodegenerative diseases. The company, through its NurOwn proprietary cell therapy platform, leverages cell culture methods to induce autologous bone marrow-derived mesenchymal stem ...
More about BCLI
Track This Portfolio

Track Jump Financial, LLC Portfolio

Follow Jump Financial, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jump Financial, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jump Financial, LLC with notifications on news.